Business Wire

Insights on the $26.1 Billion Psoriasis Treatment Global Market to 2027 – Featuring AbbVie, Amgen, Novartis International and Pfizer Among Others – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Psoriasis Treatment: Global Strategic Business Report” report has been added to ResearchAndMarkets.com’s offering.

The global market for Psoriasis Treatment estimated at US$16.9 Billion in the year 2020, is projected to reach a revised size of US$26.1 Billion by 2027, growing at a CAGR of 6.4% over the analysis period 2020-2027.

Interleukin Inhibitors, one of the segments analyzed in the report, is projected to record a 6.1% CAGR and reach US$9.6 Billion by the end of the analysis period.

Taking into account the ongoing post pandemic recovery, growth in the Corticosteroids segment is readjusted to a revised 6.1% CAGR for the next 7-year period.

The U.S. Market is Estimated at $4.6 Billion, While China is Forecast to Grow at 11% CAGR

The Psoriasis Treatment market in the U.S. is estimated at US$4.6 Billion in the year 2020. China, the world’s second largest economy, is forecast to reach a projected market size of US$5.6 Billion by the year 2027 trailing a CAGR of 10.8% over the analysis period 2020 to 2027.

Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.8% and 6.4% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.5% CAGR. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$3.5 Billion by the year 2027.

Tumor Necrosis Factor (TNF) Inhibitors Segment to Record 7.3% CAGR

In the global Tumor Necrosis Factor (TNF) Inhibitors segment, USA, Canada, Japan, China and Europe will drive the 7.3% CAGR estimated for this segment.

These regional markets accounting for a combined market size of US$2.4 Billion in the year 2020 will reach a projected size of US$3.8 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Latin America will expand at a 8.9% CAGR through the analysis period.

Select Competitors (Total 44 Featured) –

  • AbbVie, Inc.
  • Amgen, Inc.
  • Eli Lilly and Company
  • Johnson & Johnson
  • Merck & Co., Inc.
  • Novartis International AG
  • Pfizer, Inc.

Key Topics Covered:

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Influencer Market Insights
  • World Market Trajectories
  • Psoriasis Treatment – Global Key Competitors Percentage Market Share in 2022 (E)
  • Competitive Market Presence – Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
  • Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS

IV. COMPETITION

For more information about this report visit https://www.researchandmarkets.com/r/eb4rw9

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Articles

Back to top button